Explore our handpicked selection of best-selling items loved by our customers. Each product is crafted to deliver quality, performance, and value — find your perfect match today.
ZogniQ ZPL is built around a suite of advanced features, making it the preferred choice for ophthalmology, optometry, dermatology, and many other medical specialties
Multi-Wavelength Precision: Harnesses the power of polarized red, blue, yellow and infrared wavelengths—each selected for optimal tissue penetration and cellular effect.
Polarized Resonance Technology: Program individual polarized light frequencies as well as combinations of multiple light frequencies and intensities to match specific treatment goals.
Pre and Post Treatment 8K Image capture: By integrating ultra-high-resolution (8K) imaging with multiple wavelengths of polarized light, advanced AI technology can significantly improve diagnostic accuracy for ocular conditions such as dry eye, meibomian gland dysfunction, and blepharitis, as well as a broad spectrum of skin, facial and ocular disorders
Advanced AI-Connected Platform: A future-ready investment featuring automatic software updates, remote diagnostics, and a robust AI-driven roadmap, including patent-pending functionality designed to expand capabilities over time.
ZogniQ™ is a next-generation polarized light therapy system (ZPL) designed to deliver precise, reproducible therapeutic outcomes for ocular, dermatologic, and other medical conditions.
Unlike standard devices, ZogniQ ZPL utilizes polarized light for deeper tissue penetration and enhanced cellular interaction. It also integrates AI-powered imaging and analysis for precise treatment planning and monitoring.
ZogniQ ZPL is designed for a wide range of clinical uses, including ocular conditions (dry eye, meibomian gland dysfunction, blepharitis), dermatology (skin rejuvenation, wound healing, inflammation), and broader therapeutic wellness applications.
Yes. The system uses Patent Pending non-invasive polarized light therapy with built-in safety features like IR, ToF-guided distance monitoring, audible/visual alerts, and precision-controlled energy delivery. Unlike any other system on the market.
The ToF sensor ensures accurate device positioning relative to the patient’s face or treatment area, with real-time proximity alerts and automated energy calculations (J/cm²) for each wavelength—supporting reproducibility and safety.
The recommended frequency of use depends on the condition being treated. For ocular rosacea, Demodex, dry eye, or meibomian gland dysfunction (MGD), begin with an initial procedure followed by three additional sessions every 1–2 weeks. For wrinkle reduction, treatments are typically repeated weekly for 4–6 sessions. In some cases, noticeable improvements may require several months of consistent use.
ZogniQ ZPL incorporates machine learning and AI to analyze ultra-high-resolution (8K) polarized images before and after treatment, helping physicians optimize protocols and track outcomes with accuracy.
The touchscreen provides clear visualization of treatment parameters, multi-parameter display, easy navigation, and room for AI-driven upgrades—making treatments more efficient and precise.
ZogniQ ZPL offers advanced customization options, allowing clinicians to tailor sessions for ocular conditions, dermatology, acute pain, chronic conditions, or general wellness with adjustable wavelengths, intensity, and duration settings.
Yes. ZogniQ ZPL is a software-driven platform with automatic updates. Physicians can also access ZPL treatment protocols developed by leading ophthalmic, optometric and other medical experts.
The platform includes automatic software updates, remote diagnostics, and a robust AI-driven roadmap, with patent-pending features designed to expand functionality over time.
